Medtronic's Trading Volume Drops 54.29% to $474 Million Ranking 164th in Market

On June 23, 2025, Medtronic's trading volume was $474 million, a 54.29% decrease from the previous day, ranking 164th in the day's stock market. Medtronic's stock price fell by 0.42%.

Medtronic, a global leader in healthcare technology, has expanded its Board of Directors by appointing Dr. Joon Lee, the CEO of Emory Healthcare, as a new independent director. Dr. Lee's extensive experience in healthcare leadership is expected to enhance Medtronic's mission to leverage data and technology for improving patient and provider experiences. He will serve on the Science and Technology Committee and the Compensation and Talent Committee.

Dr. Lee's appointment aligns with Medtronic's strategic focus on high-margin growth areas and its commitment to advancing healthcare solutions globally. His expertise is anticipated to drive the company's solid financial performance and reinforce its ability to navigate challenges such as tariffs and currency headwinds.

Medtronic, headquartered in Galway, Ireland, is known for developing innovative solutions to address complex health challenges. The company offers a range of products, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems. With a mission to alleviate pain, restore health, and extend life, Medtronic operates in over 150 countries with a workforce of more than 95,000 employees.